Physician profile
Dawna K Smith
NPI 1225660699
$1,073.68
in general payments reported to CMS, 2019-2025
20 companies · $181 in 2025
The $181 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $301 · 2024: $592 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,074.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,073.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $296.60 | 2023-2025 | |
| Lilly USA, LLC | $166.54 | 2023-2024 | Zepbound, Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals Lp | $101.19 | 2023-2024 | Farxiga, Airsupra |
| Amgen INC. | $75.34 | 2024-2025 | Otezla, Repatha, Evenity |
| Novo Nordisk INC | $74.33 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Abbott Laboratories | $46.14 | 2025 | Freestyle Libre 3 |
| Corium, LLC | $41.02 | 2023-2024 | Azstarys |
| Nevro Corp. | $34.97 | 2023-2024 | Senza |
| Merck Sharp & Dohme LLC | $28.38 | 2023 | Belsomra, Steglatro |
| Sumitomo Pharma America, INC. | $27.44 | 2024 | Gemtesa |
| Astellas Pharma US INC | $24.47 | 2024 | Veozah |
| Phadia US INC. | $24.13 | 2024 | Immunocap |
| Idorsia Pharmaceuticals US INC | $22.66 | 2023 | Quviviq |
| Verrica Pharmaceuticals INC. | $20.52 | 2024 | Ycanth |
| Glaxosmithkline, LLC. | $18.69 | 2023 | Trelegy Ellipta |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $15.43 | 2024 | Thinprep 2000 Processor, Aptima |
| Boston Scientific Corporation | $15.04 | 2024 | Watchman Flx |
| Exact Sciences Corporation | $13.99 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $13.51 | 2023 | |
| Axsome Therapeutics, INC. | $13.29 | 2024 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawna Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.